Complete Story
08/30/2017
NCCN has published updates to the NCCN Guidelines® and the NCCN Compendium® for Ovarian Cancer
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and the NCCN Drugs & Biologics Compendium (NCCN Compendium®) for Ovarian Cancer. These NCCN Guidelines® are currently available as Version 3.2017.
- Complete Remission and Relapse ≥6 months After Completing Prior Chemotherapy (OV-6)
- Olaparib has been added as a maintenance therapy option for consideration if there is a partial or complete response after two or more lines of platinum-based therapy for those with platinum-sensitive disease.
NCCN has published the following updated NCCN Guidelines® with NCCN Evidence Blocks™:
Ovarian Cancer, Version 3.2017
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!